A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

• Status: Completed
• Trial end date: 2010-07-01

Summary

The purpose of this study is to assess the potential effect and safety of multiple oral doses of dexlansoprazole, lansoprazole, omeprazole or esomeprazole, once daily (QD), on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel, and to assess the safety of multiple doses of clopidogrel in healthy participants.

• Phase: Phase 1

Details

• Lead Sponsor: Takeda
• Treatments: Clopidogrel; Dexlansoprazole; Esomeprazole; Lansoprazole; Omeprazole; Ticlopidine